Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun 6;116(12):1513-1519.
doi: 10.1038/bjc.2017.99. Epub 2017 Apr 27.

A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases

Affiliations
Review

A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases

Muhammed R S Siddiqui et al. Br J Cancer. .

Abstract

Background: Pathological extramural vascular invasion (EMVI) is an independent prognostic factor in rectal cancer, but can also be identified on MRI-detected extramural vascular invasion (mrEMVI). We perform a meta-analysis to determine the risk of metastatic disease at presentation and after surgery in mrEMVI-positive patients compared with negative tumours.

Methods: Electronic databases were searched from January 1980 to March 2016. Conventional meta-analytical techniques were used to provide a summative outcome. Quality assessment of the studies was performed.

Results: Six articles reported on mrEMVI in 1262 patients. There were 403 patients in the mrEMVI-positive group and 859 patients in the mrEMVI-negative group. The combined prevalence of mrEMVI-positive tumours was 0.346(range=0.198-0.574). Patients with mrEMVI-positive tumours presented more frequently with metastases compared to mrEMVI-negative tumours (fixed effects model: odds ratio (OR)=5.68, 95% confidence interval (CI) (3.75, 8.61), z=8.21, df=2, P<0.001). Patients who were mrEMVI-positive developed metastases more frequently during follow-up (random effects model: OR=3.91, 95% CI (2.61, 5.86), z=6.63, df=5, P<0.001).

Conclusions: MRI-detected extramural vascular invasion is prevalent in one-third of patients with rectal cancer. MRI-detected extramural vascular invasion is a poor prognostic factor as evidenced by the five-fold increased rate of synchronous metastases, and almost four-fold ongoing risk of developing metastases in follow-up after surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The proportion of patients with rectal cancer who have extramural vascular invasion identified on MRI at the time of presentation.
Figure 2
Figure 2
The proportion of patients with metastases at the time of presentation who have mrEMVI-positive tumours vs mrEMVI-negative tumours.
Figure 3
Figure 3
The proportion of patients who develop metastases after surgery who had mrEMVI-positive tumours before surgery vs mrEMVI-negative tumours before surgery.

Similar articles

Cited by

References

    1. Battersby NJ, How P, Moran B, Stelzner S, West NP, Branagan G, Strassburg J, Quirke P, Tekkis P, Pedersen BG, Gudgeon M, Heald B, Brown G Group, MIS (2016) Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: The MERCURY II Study. Ann Surg 263: 751–760. - PubMed
    1. Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, Vieth M, Hoefler G, Langner C (2012) Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer 118: 628–638. - PubMed
    1. Bhangu A, Fitzgerald JE, Slesser A, Northover JM, Faiz O, Tekkis P (2013) Prognostic significance of extramural vascular invasion in T4 rectal cancer. Colorectal Dis 15: e665–e671. - PubMed
    1. Borenstein M, HL, Higgins J, Rothstein H (ed.) (2005) ComprehensiveMeta-analysis Version 2. Englewood, NJ, USA.
    1. Brown CE, Warren S (1938) Visceral metastasis from rectal carcinoma. Surg Gynecol Obstet 66: 611–621.